CS Paper Radar

Compiling, Validating, and Using Human Reference Atlas Cell Type Annotation Crosswalks

Nicole Vasilevsky, Aleix Puig-Barbe, Andreas Bueckle, Ellen M. Quardokus, Yongxin Kong, Divya Prasanth Paraman, Jie Zheng, Yongqun He, Yashvardhan Jain, Bruce W. Herr, Katy Börner

cs.HC ·submitted 2026-11-04 03:23 UTC · v1

Abstract

The Human Reference Atlas (HRA) v2.5 includes 4,807 anatomical structures, 1,347 cell types, and 2,215 biomarkers (genes, proteins, lipids); 81 organs with 1,392 anatomical structures modeled in three dimensions (3D). Mapping new data into the HRA requires 3D spatial registration and/or cell type annotation (CTann). Many CTann tools exist but few use cell type names linked to Cell Ontology (CL), making comparisons across tools, tissues, and organs difficult. The HRA supports five transcriptomics CTann tools (Azimuth, CellTypist, popV, FR-Match, Pan-Human Azimuth), four sc-proteomics CTann tools (DeepCell Types, DeepCell Types-HuBMAP, Robust Image-Based Cell Annotator [RIBCA], and SpaTial cELl LeARning [STELLAR]), plus a Cell Distance Explorer (CDE) Spatial Omics collection covering previously published annotations across 12 tissue types with 47,349,496 cells. Assigned cell types differ in number, resolution, and coverage. This paper details how 10 crosswalks were constructed, validated, and used to compile a "Supertree" that can be used to compare CTann across organs and technologies in support of reference atlas constitution and usage. All data and code can be accessed at https://cns-iu.github.io/hra-ctann-supporting-information.

Closest papers

Nearest neighbours by meaning across the whole index.

CellPath-Bench: A Multidimensional Benchmark for Whole-Slide Cellular Representations in Pathology Foundation Models

cs.AI cs.CV ·2026-08-21 ·Bokai Zhao, Yiyang Zhang, Hanqing Chao, Yawei Ma, Long Bai +4 more
benchmark similarity 0.59
Abstract

Pathology foundation models (PFMs) are increasingly used as general-purpose backbones, yet existing benchmarks cannot systematically diagnose their whole-slide cellular representation capabilities, including the decodability of cell-type information and the transferability of such information across tissue sections, datasets, and anatomical organs. We introduce CellPath-Bench, a cellular-resolution benchmark that evaluates frozen PFMs themselves. Following quality control of 52 candidate Xenium datasets, we construct a panel of 25 spatially aligned H\&E--Xenium tissue sections spanning 11 organs and 7,079,283 cells, harmonized into fine- and coarse-grained taxonomies. CellPath-Bench samples frozen WSI feature maps at registered nuclear coordinates and evaluates them using standardized multiclass linear probes. Cell Representation Advantage (CRA) measures the within-section advantage of nucleus-anchored representations over patch-level mean pooling, while Cell Representation Transferability (CRT) characterizes the generalization of cell-type decodability across tissue sections, datasets, and organs. We benchmark 30 pathology-specific and general-purpose foundation models through 304,920 runs across spatial readouts, magnifications, taxonomic granularities, and evaluation protocols. The results reveal substantial model-dependent differences in cell-type decodability and its cross-domain generalization, yielding distinct multidimensional capability profiles. CellPath-Bench provides a standardized framework for auditing cellular information in frozen PFM representations.

0.33

CytoFormer: A Molecularly Supervised Cell Foundation Model for Histopathology Cell Classification

cs.CV ·2026-08-17 ·Jialu Yao, Songhao Li, Alina Yu, Zhi Huang
published similarity 0.58
Abstract · 20 pages, 5 figures, 2 extended data figures

Identifying cell types directly from routine haematoxylin and eosin (H&E) histology would enable single-cell analysis at scale, but training such models has relied on manual pathologist annotations, which are slow, expensive and unreliable for many cell types. We instead supervise morphology with molecules. Imaging-based spatial transcriptomics profiles individual cells in situ on a section that can afterwards be stained with H&E, so that molecular identity and morphology are observed for the same physical cell. We assembled 81 such paired Xenium sections spanning 16 organs, derived per-cell labels by clustering, marker-gene annotation, organ-wise human review and quality control, and mapped them onto the cell types commonly reported in each organ. This yielded 15.4 million cells, each with a paired H&E image patch and one of 23 cell types, on which we trained CytoFormer, a cell foundation model with a multi-task, per-organ classification head. On spatially held-out tissue CytoFormer reached an accuracy of 0.85 and a macro-F1 of 0.78 across all 16 organs, and its predictions reproduced the tissue architecture of an entire held-out section. The representation also transfers: with the encoder frozen, a linear head on CytoFormer features performed better than six pathology foundation models on four expert-annotated benchmarks, including on organs and cell types that were not part of pretraining. Finally, in an interactive active-learning setting, CytoFormer's embeddings are markedly more label-efficient than existing pathology foundation models, detecting normal epithelium amid look-alike tumour with an F1 of 0.82 from only a few annotations and leading the strongest baseline by 0.13 in F1. CytoFormer turns paired H&E and spatial transcriptomics into a reusable, label-efficient representation for cell-level analysis of routine histology.

0.60

Research Collaborations Within and Across Disciplines in NIH-Funded Atlas Programs

cs.SI cs.DL ·2026-11-06 ·Michael P. Ginda, Yongxin Kong, Katy Börner
similarity 0.55
Abstract

The National Institutes of Health (NIH) fund several programs (aka consortia) that support the construction of organ-specific or whole person atlases. These initiatives are designed to build comprehensive open reference datasets while advancing knowledge graphs, analytics, visualizations, and user interfaces needed to explore multiscale human atlas data. Here, we compare the Human Tumor Atlas Network (HTAN), Human BioMolecular Atlas Program (HuBMAP) and Cellular Senescence Network (SenNet) to examine collaboration by consortium component (CC) and researcher role and its relation to scientific impact. We retrieved 884 NIH award records and identified 1,255 focal publications acknowledging these awards, involving 8,952 researchers; compiled 99,108 citing publications covering 93% of the focal publications; constructed co-authorship networks; and as single-project publications or internal collaborations (IC), including intra-CC and inter-CCs collaborations. within each atlas program. Results show that IC publications are rare but involve many funded projects and principal investigators (PIs). Technology-oriented CCs tend to engage in intra-CC collaboration, whereas experimental-oriented CCs often collaborate across CCs of the same type. Compared with other researchers, PIs exhibited a significantly stronger association with inter-CCs than with single-project publications. IC publications have higher mean Relative Citation Ratios than single-project publications. Inter-CCs publications have significantly higher cumulative and annual citation levels in the first five post-publication years. Study methods and results can be used to inform the funding, management, and impact reporting for future Big Science programs that bring together 300+ experts from different disciplines to address major research challenges.

0.23

VizIt: A multi-view framework for exploring single-cell, spatial, and genetic data online

cs.IR q-bio.GN ·2026-09-04 ·Chenhang Christopher Zhang, Yanqing Lou, Jie Yuan, Mingming Lu, Jacob Parker +6 more
code/dataunusual similarity 0.55
Abstract

Multi-omic studies increasingly require data to be examined from complementary biological perspectives, yet interactive exploration remains fragmented across modalities and tools. We present VizIt, an open-source framework for multi-view exploration of single-cell and spatial transcriptomic, epigenomic and genetic data. VizIt connects gene-, cell type-, condition-, spatial-, genomic region- and variant-centered views, enabling seamless navigation across biological perspectives. We demonstrate VizIt through the Parkinson's Cell Atlas, a customizable interactive multi-omic resource.

0.35

spora: A Unified Multimodal Dataset and Platform for Spatial Proteomics

cs.CV cs.AI ·2026-10-15 ·Benedikt von Querfurth, Johann Wenckstern, Eeshaan Jain, Lukas Klein, Phil Cheng +7 more
top venuebenchmark similarity 0.54
Abstract · Accepted to NeurIPS 2026

Spatial proteomics (SP) captures the molecular composition and spatial organization of tissues at single-cell resolution, opening a direct view of the cellular ecosystems that drive disease. Protein panels, acquisition platforms, and tissue contexts differ from one cohort to the next, and a coherent picture of tissue biology can only emerge from models trained to bridge this heterogeneity. Foundation models offer the natural path forward, but their training depends on large, harmonized corpora that span platforms, panels, and cohorts. No public resource currently approaches that scale; available data sit in small, narrowly scoped releases with incompatible formats and conventions. We present $\texttt{spora}$, a large-scale multimodal SP dataset of 13,546 standardized multiplex images from 5,477 patients across 35 cohorts and five major SP technologies. Curated with biomedical experts, $\texttt{spora}$ provides model training-ready formats together with cell and tissue segmentations, structured clinical metadata, and, where available, paired H&E enabling the training of virtual staining models. It is complemented by $\texttt{spora [io]}$, a unified interface for tiling, sampling, and standardization across all cohorts and modalities, and $\texttt{spora [bench]}$, a benchmark suite spanning cell phenotyping, diagnostic and therapeutic prediction as well as virtual staining tasks across twelve cohorts that places current SP foundation models on common ground against task specific baselines.

0.52

CellPlex: Benchmarking Single-Cell Spatial Proteomics Prediction from H&E

cs.CV ·2026-11-02 ·Zijun Gao, Yijiang Chen, Xiangde Luo, Pheng-Ann Heng
benchmark similarity 0.54
Abstract

Spatial proteomics measures tens of proteins in every cell of a tissue section, but its cost confines it to small research cohorts, whereas hematoxylin and eosin (H\&E) slides exist for nearly every patient. Inferring single-cell spatial proteomics from H\&E would bring its analyses to routine pathology, and a growing number of virtual staining models pursue this goal. Each is evaluated on its own cohort, panel and pixel-level metric, and released models transfer poorly to new cohorts, leaving open which approach to build on and which proteins H\&E can reveal. We introduce CellPlex, a benchmark that poses the task at the level of the cell: seven cohorts with same-section H\&E and multiplexed immunofluorescence, from colorectal and breast cancer to lymph-node metastases, bone marrow and glioma, with 717 samples, 44.8 million cells and 149 proteins, processed by one pipeline into per-cell targets. Pathology foundation models (PFMs) are adapted with one cell-level protocol, specialist models are fine-tuned under a matched budget, and all are scored on the same cells. Adapted PFMs are the most accurate models on every cohort, ahead of the specialists even after fine-tuning, but keep less than half of their accuracy on cohorts they were not trained on. Which proteins can be predicted depends on the tissue, not on how many cells were measured for them. By fixing the cells, targets and splits on which predictions are judged, CellPlex sets a common standard for inferring costly molecular measurements from routine H\&E and shows how far H\&E can stand in for spatial proteomics. We will release the data, splits, evaluation code and baselines as a testbed for developing and comparing future pathology foundation models and virtual staining methods.

0.21

STP-BENCH: A Unified Systematic Benchmark for Virtual Spatial Transcriptomics from Histopathology Images

cs.CV ·2026-09-05 ·Youngmin Chung, Ji Hun Ha, Andrew H. Song, Cristina Almagro-Pérez, Chaeyoung Seo +6 more
benchmarkcode/data similarity 0.54
Abstract

Spatial transcriptomics (ST) provides unprecedented insights into tumor heterogeneity by capturing spatially resolved gene expression, yet its high experimental cost hinders large-scale adoption. Consequently, computational approaches that predict spatial gene expression directly from hematoxylin and eosin slides, termed virtual ST, have rapidly emerged. Despite this progress, assessing advances in the field remains difficult due to insufficient benchmarking: prior studies rely on small, heterogeneous datasets, inconsistent training and inference pipelines, and limited evaluation of biological interpretability and model robustness. To address these gaps, we present STP-BENCH, a standardized benchmark for virtual ST models. STP-BENCH comprises six cancer types spanning two ST platforms (Visium and Xenium), with each training dataset containing more than 30,000 spots and at least 15 slides to ensure statistical reliability. We evaluate 21 predictive approaches, re-implemented with a unified pathology foundation model as the morphological encoder when architecturally applicable. Beyond conventional benchmarks that report average predictive accuracy on highly variable genes, we systematically examine which genes and gene sets are recoverable from histomorphology. We further evaluate the downstream biological utility of predicted profiles through cell-type deconvolution and spatial domain identification, and assess model reliability under domain shifts and data scaling. Notably, unified morphological encoding substantially re-orders model rankings established in prior studies, indicating that architectural innovations and image encoding have been conflated in previous evaluations. We publicly release STP-BENCH to support reproducibility and serve as a community benchmark at https://github.com/NEXGEM/STP-Bench.

0.38

HEmIF-Bench: Benchmarking H&E-to-mIF Models BeyondVirtual-StainFidelity

cs.CV ·2026-11-15 ·Fuxian Zhao, Hyokeun Park
benchmark similarity 0.54
Abstract · 11 pages, 3 figures, 2 tables

Hematoxylin and eosin (H&E)-to-multiplex immunofluorescence (mIF) generators predict spatial protein expression from routine histology, yet pixel-level marker reconstruction does not establish downstream utility. We present HEmIF-Bench, evaluating five frozen generators across eight datasets spanning molecular, cellular, tissue, and patient scales. HEmIF-Bench decouples internal encoder features from generated outputs, benchmarking both against the pathology foundation reference UNI2. Mirroring the clinical workflow where pathologists rely on mIF to define cell phenotypes, delineate tertiary lymphoid structures (TLSs) and germinal centers (GCs), and stratify patient risk, we evaluate external CD3 recovery, single-cell classification, dense nuclear segmentation, TLS/GC segmentation, and patient survival prediction. Across the benchmark, foundation-model-based MIPHEI-ViT leads among the generators, while non-foundation models show task-specific strengths. Comparing the two routes reveals that internal encoder features generally outperform generated outputs, and larger output marker panels do not guarantee stronger downstream utility across datasets. Moreover, neither internal encoder features nor generated outputs consistently surpass frozen UNI2. These findings show that pixel-level stain fidelity does not equate to downstream utility, and that generators trained at current paired-data scales have yet to surpass large-scale pure-H&E foundation models. With the expansion of paired translation cohorts and the advancement of foundation-based generative architectures, HEmIF-Bench establishes a definitive benchmark for tracking when H&E-to-mIF generation crosses the threshold to deliver genuine value beyond routine histology for tumor microenvironment analysis and precision oncology.

0.13